Topical vitamin D₃ nasal irrigation for sinonasal inflammation

Technology
In development
University

A novel nasal irrigation therapy using topical vitamin D₃ for treating sinonasal inflammation, offering a natural, non-steroidal alternative to traditional treatments with potential for holistic respiratory care.

Overview

Topical Vitamin D₃ nasal irrigation presents a promising natural therapy for sinonasal inflammation conditions such as allergic rhinitis and chronic rhinosinusitis. This innovative approach uses high-volume nasal rinses to deliver active vitamin D₃ directly to the nasal mucosa, targeting inflammation and supporting mucosal immunity. By bypassing systemic metabolism, this method offers a more effective delivery of vitamin D's anti-inflammatory and barrier-restoring benefits compared to oral supplementation. This therapy aims to provide a scalable, low-toxicity alternative to synthetic antihistamines, aligning with trends in holistic and respiratory health care.

Technical specifications

Key features:

  • Utilizes high-volume nasal irrigation for direct delivery to nasal tissues
  • Targets sinonasal inflammation with active vitamin D₃, a compound known for its anti-inflammatory properties
  • Designed for safety and tolerability, providing potential relief from symptoms such as congestion and sneezing
  • Includes a comprehensive clinical trial to evaluate efficacy, involving assessments of symptom scores and immune biomarkers like cathelicidin and cytokines
Technology readiness level

The technology is currently at TRL 4, having been validated in preclinical models. A clinical trial is planned to further evaluate its safety and efficacy in human subjects, focusing on symptom improvement and immune biomarker changes.


About University of North Carolina, Chapel Hill

UNC–Chapel Hill is a comprehensive public research university and the state’s flagship, pairing broad academic depth with a major academic health system. Industry partners access co‑located core facilities, sponsored research, and an on‑campus innovation hub that connects companies to faculty and advanced instrumentation. Integration with a major hospital system and statewide clinics enables patient access, clinical trials, and real‑world evidence collaborations. Minutes from Research Triangle Park, the university works within a dense corporate R&D ecosystem. Research is supported by strong competitive federal funding, including NIH and NSF, and a dedicated technology transfer office streamlines IP, licensing, MTAs, and startup formation.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.